Pontus Plavén-Sigray Selected Research

Pontus Plavén-Sigray Research Topics

6	Psychotic Disorders (Schizoaffective Disorder) 02/2024 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2022
3	Parkinson Disease (Parkinson's Disease) 11/2022 - 01/2021
3	Schizophrenia (Dementia Praecox) 01/2022 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 01/2022
2	Cognitive Dysfunction 02/2024 - 10/2023
2	Mental Disorders (Mental Disorder) 01/2023 - 01/2018
2	Alcoholism (Alcohol Abuse) 01/2023 - 01/2021
1	Tauopathies 04/2024
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Proteostasis Deficiencies 01/2022
1	Dementia (Dementias) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 10/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Parkinson Disease 16 01/2021
1	Antisocial Personality Disorder (Antisocial Personality) 01/2018
1	Social Phobia 01/2017

3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
3	Antipsychotic Agents (Antipsychotics)IBA 02/2024 - 09/2021
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2023 - 01/2021
3	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2022
2	SynucleinsIBA 11/2022 - 01/2022
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 04/2024
1	MTOR InhibitorsIBA 04/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Sirolimus (Rapamycin)FDA Link 04/2024
1	Polytetrafluoroethylene (Teflon)FDA Link 02/2024
1	Escitalopram FDA Link 10/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	RacloprideIBA 01/2023
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2021
1	FLB 457IBA 09/2021
1	LigandsIBA 01/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2021
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018

1	Neurosurgical Procedures 01/2022
1	Injections 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Aftercare (After-Treatment) 10/2021